Trial intelligence / Profile preview

Phase 2 Study of Avapritinib in Indolent and Smoldering Systemic Mastocytosis

2018-000588-99Phase 2Unknown

Sponsor

Blueprint Medicines

Start

Oct 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1